BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 7717983)

  • 1. Quantification of a matrix metalloproteinase-generated aggrecan G1 fragment using monospecific anti-peptide serum.
    Lark MW; Williams H; Hoernner LA; Weidner J; Ayala JM; Harper CF; Christen A; Olszewski J; Konteatis Z; Webber R
    Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):245-52. PubMed ID: 7717983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B.
    Fosang AJ; Neame PJ; Last K; Hardingham TE; Murphy G; Hamilton JA
    J Biol Chem; 1992 Sep; 267(27):19470-4. PubMed ID: 1326552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain.
    Fosang AJ; Last K; Knäuper V; Neame PJ; Murphy G; Hardingham TE; Tschesche H; Hamilton JA
    Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):273-6. PubMed ID: 8216228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunolocalization of the cleavage of the aggrecan core protein at the Asn341-Phe342 bond, as an indicator of the location of the metalloproteinases active in the lysis of the rat growth plate.
    Lee ER; Lamplugh L; Leblond CP; Mordier S; Magny MC; Mort JS
    Anat Rec; 1998 Sep; 252(1):117-32. PubMed ID: 9737748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a cleavage-site-specific monoclonal antibody for detecting metalloproteinase-derived aggrecan fragments: detection of fragments in human synovial fluids.
    Fosang AJ; Last K; Gardiner P; Jackson DC; Brown L
    Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):337-43. PubMed ID: 7544117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the interglobular domain of aggrecan alter matrix metalloproteinase and aggrecanase cleavage patterns. Evidence that matrix metalloproteinase cleavage interferes with aggrecanase activity.
    Mercuri FA; Maciewicz RA; Tart J; Last K; Fosang AJ
    J Biol Chem; 2000 Oct; 275(42):33038-45. PubMed ID: 11032846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interglobular domain of cartilage aggrecan is cleaved by hemorrhagic metalloproteinase HT-d (atrolysin C) at the matrix metalloproteinase and aggrecanase sites.
    Tortorella MD; Pratta MA; Fox JW; Arner EC
    J Biol Chem; 1998 Mar; 273(10):5846-50. PubMed ID: 9488721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteoglycan-degrading activity of human stromelysin-1 and leukocyte elastase in rabbit joints. Quantitation of proteoglycan and a stromelysin-induced HABR fragment of aggrecan in synovial fluid and cartilage.
    Olszewski JM; Moore VL; McDonnell J; Williams H; Saphos CA; Green BG; Knight WB; Chapman KT; Hagmann WK; Dorn CP; Hale JJ; Mumford RA
    Connect Tissue Res; 1996; 33(4):291-9. PubMed ID: 8834447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin B: an alternative protease for the generation of an aggrecan 'metalloproteinase' cleavage neoepitope.
    Mort JS; Magny MC; Lee ER
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):491-4. PubMed ID: 9794785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 45 kDa collagen-binding fragment of fibronectin induces matrix metalloproteinase-13 synthesis by chondrocytes and aggrecan degradation by aggrecanases.
    Stanton H; Ung L; Fosang AJ
    Biochem J; 2002 May; 364(Pt 1):181-90. PubMed ID: 11988091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of an antibody against the matrix metalloproteinase-generated aggrecan neoepitope FVDIPEN-COOH to assess the effects of stromelysin in a rabbit model of cartilage degradation.
    Bayne EK; MacNaul KL; Donatelli SA; Christen A; Griffin PR; Hoerrner LA; Calaycay JR; Ayala JM; Chapman K; Hagmann W
    Arthritis Rheum; 1995 Oct; 38(10):1400-9. PubMed ID: 7575690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro.
    Hughes CE; Caterson B; Fosang AJ; Roughley PJ; Mort JS
    Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):799-804. PubMed ID: 7531436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent.
    Fosang AJ; Last K; Maciewicz RA
    J Clin Invest; 1996 Nov; 98(10):2292-9. PubMed ID: 8941646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1mut at the 'aggrecanase' and the MMP sites. Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan.
    Büttner FH; Hughes CE; Margerie D; Lichte A; Tschesche H; Caterson B; Bartnik E
    Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):159-65. PubMed ID: 9639575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High pressure gel-permeation assay for the proteolysis of human aggrecan by human stromelysin-1: kinetic constants for aggrecan hydrolysis.
    Poe M; Stein RL; Wu JK
    Arch Biochem Biophys; 1992 Nov; 298(2):757-9. PubMed ID: 1417002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373-A374 in the interglobular domain of cartilage aggrecan.
    Fosang AJ; Last K; Neame PJ; Murphy G; Knäuper V; Tschesche H; Hughes CE; Caterson B; Hardingham TE
    Biochem J; 1994 Dec; 304 ( Pt 2)(Pt 2):347-51. PubMed ID: 7998967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. Evidence for proteolysis at this site in vivo in human articular cartilage.
    Flannery CR; Lark MW; Sandy JD
    J Biol Chem; 1992 Jan; 267(2):1008-14. PubMed ID: 1730630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments.
    Struglics A; Larsson S; Pratta MA; Kumar S; Lark MW; Lohmander LS
    Osteoarthritis Cartilage; 2006 Feb; 14(2):101-13. PubMed ID: 16188468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4).
    Tortorella MD; Pratta M; Liu RQ; Austin J; Ross OH; Abbaszade I; Burn T; Arner E
    J Biol Chem; 2000 Jun; 275(24):18566-73. PubMed ID: 10751421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMPs are less efficient than ADAMTS5 in cleaving aggrecan core protein.
    Durigova M; Nagase H; Mort JS; Roughley PJ
    Matrix Biol; 2011 Mar; 30(2):145-53. PubMed ID: 21055468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.